UK shares little changed, GSK gains

UK shares were steady on Monday as investors largely opted for a wait-and-watch approach amid simmering U.S.-China trade tensions and Brexit worries, and a lack of significant corporate news. The exporter-heavy FTSE 100 index was roughly flat, though GlaxoSmithKline added 2% after its maintenance therapy for a form of ovarian cancer reduced the risk of disease progression or death by 38% in a late-stage study.

The mid-cap FTSE 250 was also flat by 0709 GMT.

Also Read: CORRECTED- Investors turn heat on Big Oil ahead of U.N. climate summit